At Bluelight.org we encourage collaborative partnerships between academic researchers and our community. In 2016 we were approached by Liam Engel with a proposal to utilise data from Bluelight for his PhD, using an engaged and participatory approach. Liam is now Dr Engel (well done!) and we are thrilled to announce research from our collaboration has been published in the journal Addiction Research and Theory.
Abstract:
Through this analysis, the authors came up with some strategies about ways in which we can promote more positivity when discussing drugs:
1. Respect the unique and valuable drug knowledge of consumers,
2. Subvert and challenge stigmatising terms,
3. Favour benefit maximisation over harm reduction,
4. Recognise the diversity of drug use,
5. Acknowledge the support and altruism of drug communities.
The publisher’s version of this paper can be accessed, but if you can’t get around the paywall, you can also access a PDF of the accepted manuscript.
Feel free to comment on the paper here - we'd love to hear your views on it.
Abstract:
People who use drugs understand drugs and drug use in ways that are often different to the way knowledge of drug use is constructed within the dominant medico-legal discourse. Their experiences are, more often than not, represented in negative ways within dominant discourse, a disconnect that can create adverse consequences for people who use drugs, through the production of stigma and shame leading to poor health and social outcomes. A key difference in how drugs are understood by people who use drugs is the capacity of the former to recognize positive aspects of drug use and create more agentic subjectivities for themselves concerning the use of drugs. Using a thematic analysis of the online forum Australian Drug Discussion, hosted by Bluelight.org, we identify positive drug stories and the contexts of their emergence, as subversions or modifications of dominant understandings. We argue that positive understandings of drug use, as well as recognition of the way their expression serves to generate agency for people who use drugs within or against the confines of dominant discourse, may provide opportunities to limit further the harms flowing from stigmatization and negativity.
Through this analysis, the authors came up with some strategies about ways in which we can promote more positivity when discussing drugs:
1. Respect the unique and valuable drug knowledge of consumers,
2. Subvert and challenge stigmatising terms,
3. Favour benefit maximisation over harm reduction,
4. Recognise the diversity of drug use,
5. Acknowledge the support and altruism of drug communities.
The publisher’s version of this paper can be accessed, but if you can’t get around the paywall, you can also access a PDF of the accepted manuscript.
Feel free to comment on the paper here - we'd love to hear your views on it.